Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2016
This article has no abstract
Epistemonikos ID: 32f3761173ebe0f1a0e1062899feff95f5be2934
First added on: Apr 16, 2025